Field evaluation of a rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood
Affiliation
Médecins Sans Frontières – Spain, Barcelona, Spain; Centro Universitario de Medicina Tropical - Facultad de Medicina, Universidad Mayor de San Simon, Cochabamba, Bolivia; Laboratório de Doenças Parasitárias, Instituto Oswaldo Cruz - Fiocruz, Rio de Janeiro, Brazil.Issue Date
2008-06
Metadata
Show full item recordJournal
Journal of Clinical MicrobiologyAbstract
Laboratory and clinical diagnostic classification of seropositive individuals, followed by treatment and supportive therapy, is an established component of Chagas disease control in endemic areas. However, most Chagas-infected patients live in remote areas where neither equipped laboratories nor skilled human resources are widely available. Employing a rapid diagnostic test (RDT), when using whole blood samples, is the best-option for Chagas disease control. A high sensitivity and specificity for the Chagas Stat-Pak(TM) RDT (Chembio Diagnostic Systems, Inc., Medford, NY) has been reported when assayed with serum and plasma but its validity for the detection of antibodies to Trypanosoma cruzi infection in whole blood is unknown. This cross-sectional study measured the sensitivity and specificity of the Chagas Stat-Pak(TM) when using whole blood and conventional serological assays as a comparison. The inter-observer reliability in the interpretation of the Chagas Stat-Pak(TM) results and 'ease of use' criterion needed to perform the Chagas Stat-Pak(TM) and conventional assays were also measured. The Chagas Stat-Pak(TM) yielded a high specificity [99.0%, (95%CI: 98.4%-99.4%)] but a relatively low sensitivity [93.4%, (95%CI: 87.4%-97.1%)]. The inter-observer reliability was excellent [kappa(n=1,913)= .999,(p<.0001)] and quantified 'ease of use' criterion suggested that the RDT is simple to perform. Despite the distinguished attributes of the Chagas Stat-Pak(TM), it is not an ideal diagnostic test for the population investigated in this study due to its relatively low sensitivity and high cost. The RDT manufacturer is called upon to improve the test if the international community hopes to make progress in controlling Chagasic infections in endemic areas.Publisher
American Society for MicrobiologyPubMed ID
18400910Type
ArticleLanguage
enISSN
1098-660Xae974a485f413a2113503eed53cd6c53
10.1128/JCM.02303-07
Scopus Count
Collections
Related articles
- Validation of a rapid immunochromatographic assay for diagnosis of Trypanosoma cruzi infection among Latin-American Migrants in Geneva, Switzerland.
- Authors: Chappuis F, Mauris A, Holst M, Albajar-Vinas P, Jannin J, Luquetti AO, Jackson Y
- Issue date: 2010 Aug
- [Evaluation of SD BIOLINE Chagas Ab Rapid kit].
- Authors: Ji MJ, Noh JS, Cho BK, Cho YS, Kim SJ, Yoon BS
- Issue date: 2009 Feb
- Comparison of two immunochromatographic assays and the indirect immunofluorescence antibody test for diagnosis of Trypanosoma cruzi infection in dogs in south central Louisiana.
- Authors: Nieto PD, Boughton R, Dorn PL, Steurer F, Raychaudhuri S, Esfandiari J, Gonçalves E, Diaz J, Malone JB
- Issue date: 2009 Nov 12
- Sensitivity and specificity of Chagas Stat-Pak test in Bolivia.
- Authors: Chippaux JP, Santalla JA, Postigo JR, Romero M, Salas Clavijo NA, Schneider D, Brutus L
- Issue date: 2009 Jul
- A highly sensitive rapid diagnostic test for Chagas disease that utilizes a recombinant Trypanosoma cruzi antigen.
- Authors: Barfield CA, Barney RS, Crudder CH, Wilmoth JL, Stevens DS, Mora-Garcia S, Yanovsky MJ, Weigl BH, Yanovsky J
- Issue date: 2011 Mar